These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12448654)

  • 61. Activity of gemcitabine and continuous infusion fluorouracil in advanced pancreatic cancer.
    Rauch DP; Maurer CA; Aebi S; Pampallona S; Friess H; Ludwig CU; Büchler MW; Borner MM
    Oncology; 2001; 60(1):43-8. PubMed ID: 11150907
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Leucovorin, 5-fluorouracil, and gemcitabine: a phase I study.
    Poplin E; Roberts J; Tombs M; Grant S; Rubin E
    Invest New Drugs; 1999; 17(1):57-62. PubMed ID: 10555123
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A phase I trial of BMS-247550 (NSC# 710428) and gemcitabine in patients with advanced solid tumors.
    Hensley ML; Dizon D; Derosa F; Venkatraman E; Sabbatini P; Chi DS; Dupont J; Colevas AD; Spriggs D; Aghajanian C
    Invest New Drugs; 2007 Aug; 25(4):335-41. PubMed ID: 17364235
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Combination chemotherapy of carboplatin and gemcitabine against solid tumors: a phase I trial.
    Tassinari D; Drudi G; Panzini I; Pasini G; Arcangeli V; Fochessati F; Gianni L; Mianulli AM; Oliverio G; Pasquini E; Sartori S; Ravaioli A
    Int J Clin Oncol; 2001 Dec; 6(6):279-83. PubMed ID: 11828946
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Phase I and pharmacokinetic study of two sequences of gemcitabine and docetaxel administered weekly to patients with advanced cancer.
    Bhargava P; Marshall JL; Fried K; Williams M; Lefebvre P; Dahut W; Hanfelt J; Gehan E; Figuera M; Hawkins MJ; Rizvi NA
    Cancer Chemother Pharmacol; 2001 Aug; 48(2):95-103. PubMed ID: 11561784
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Palliative first-line treatment with weekly high-dose 5-fluorouracil as 24h-infusion and gemcitabine in metastatic pancreatic cancer (UICC IV).
    Roehrig S; Wein A; Albrecht H; Konturek PC; Reulbach U; Männlein G; Wolff K; Ostermeier N; Hohenberger W; Hahn EG; Boxberger F
    Med Sci Monit; 2010 Mar; 16(3):CR124-131. PubMed ID: 20190682
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Phase I trial of gemcitabine and paclitaxel in advanced solid tumors.
    Lim N; Lara PN; Lau DH; Edelman MJ; Tanaka M; al-Jazayrly G; Houston J; Lauder I; Gandara DR
    Cancer Invest; 2003; 21(1):7-13. PubMed ID: 12643004
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A National Cancer Institute of Canada clinical trials group phase II study of eniluracil (776C85) and oral 5-fluorouracil in patients with advanced squamous cell head and neck cancer.
    Knowling M; Browman G; Siu L; Khoo K; Cooke A; Tannock I; Klaassen D; Cripps C; Goss G; Matthews S; Clarke R; Seymour L
    Ann Oncol; 2001 Jul; 12(7):919-22. PubMed ID: 11521795
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Weekly gemcitabine and 24-hour infusional 5-fluorouracil in advanced pancreatic cancer: a phase I-II study.
    Barone C; Cassano A; Corsi DC; Pozzo C; Longo R; Schinzari G; Quirino M; Battelli C; Basso M
    Oncology; 2003; 64(2):139-45. PubMed ID: 12566911
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Phase I study of piritrexim and gemcitabine in patients with advanced solid tumors.
    Huie M; Carducci M; Liu G; Wilding G; Marnocha R; Izquierda M; Thomas J
    Am J Clin Oncol; 2005 Dec; 28(6):613-7. PubMed ID: 16317274
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Phase I clinical study of infusional 5-fluorouracil with oxaliplatin and gemcitabine (FOG regimen) in patients with solid tumors.
    Goel S; Bulgaru A; Hochster H; Wadler S; Zamboni W; Egorin M; Ivy P; Leibes L; Muggia F; Lockwood G; Harvey E; Renshaw G; Mani S
    Ann Oncol; 2003 Nov; 14(11):1682-7. PubMed ID: 14581279
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Phase I study of oral CI-994 in combination with gemcitabine in treatment of patients with advanced cancer.
    Nemunaitis JJ; Orr D; Eager R; Cunningham CC; Williams A; Mennel R; Grove W; Olson S
    Cancer J; 2003; 9(1):58-66. PubMed ID: 12602769
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pharmacology of fluorinated pyrimidines: eniluracil.
    Baker SD
    Invest New Drugs; 2000 Nov; 18(4):373-81. PubMed ID: 11081573
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Novel oral chemotherapy agents.
    Royce ME; Hoff PM; Pazdur R
    Curr Oncol Rep; 2000 Jan; 2(1):31-7. PubMed ID: 11122822
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Phase I and pharmacokinetic study of oral irinotecan given once daily for 5 days every 3 weeks in combination with capecitabine in patients with solid tumors.
    Soepenberg O; Dumez H; Verweij J; Semiond D; deJonge MJ; Eskens FA; ter Steeg J; Selleslach J; Assadourian S; Sanderink GJ; Sparreboom A; van Oosterom AT
    J Clin Oncol; 2005 Feb; 23(4):889-98. PubMed ID: 15681535
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Phase I trial using weekly administration of gemcitabine and docetaxel in patients with advanced pancreatic carcinoma.
    Meyer F; Lueck A; Hribaschek A; Lippert H; Ridwelski K
    Chemotherapy; 2004 Dec; 50(6):289-96. PubMed ID: 15608445
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Phase I trial of topotecan in combination with gemcitabine in refractory solid tumor patients.
    Nemunaitis J; Cunningham CC; Vukelja S; Ruxer RL; Adams N; Rich D; Paulson AS; MacEachern JB
    Cancer Invest; 2004; 22(3):360-7. PubMed ID: 15493356
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Gemcitabine and protracted 5-FU for advanced pancreatic cancer. A phase II study.
    Kurtz JE; Kohser F; Négrier S; Trillet-Lenoir V; Walter S; Limacher JM; Untereiner M; Kayitalire L; Jaeck D; Dufour P
    Hepatogastroenterology; 2000; 47(35):1450-3. PubMed ID: 11100374
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Eastern Cooperative Oncology Group Phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: a regimen with unexpected early toxicity.
    Talamonti MS; Catalano PJ; Vaughn DJ; Whittington R; Beauchamp RD; Berlin J; Benson AB
    J Clin Oncol; 2000 Oct; 18(19):3384-9. PubMed ID: 11013279
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dose finding and early efficacy study of gemcitabine plus capecitabine in combination with bevacizumab plus erlotinib in advanced pancreatic cancer.
    Starling N; Watkins D; Cunningham D; Thomas J; Webb J; Brown G; Thomas K; Oates J; Chau I
    J Clin Oncol; 2009 Nov; 27(33):5499-505. PubMed ID: 19858399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.